Compounds > spectinomycin
Page last updated: 2024-08-21

spectinomycin and fosfomycin

spectinomycin has been researched along with fosfomycin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Awuah, E; Barker, C; Brown, ED; Capretta, FA; Das, R; Gerritsma, DA; Lebert, J; Melacini, G; Pathania, R; Zlitni, S1
Allison, SE; Barker, CA; Brown, ED; Capretta, AA; Das, R; Melacini, G; Nguyen, ND; Zlitni, S1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dickgiesser, N; Kuntz, P1
Bordi, C; Butcher, BG; Hachmann, AB; Helmann, JD; Peters, JE; Shi, Q1

Reviews

1 review(s) available for spectinomycin and fosfomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for spectinomycin and fosfomycin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.
    Nature chemical biology, 2009, Volume: 5, Issue:11

    Topics: Anti-Bacterial Agents; Cell Division; Chromatography, Liquid; Cycloserine; Doxorubicin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Genes, Bacterial; Genome, Bacterial; Genomics; Lipoproteins; Mass Spectrometry; Molecular Chaperones; Periplasmic Binding Proteins; Pseudomonas aeruginosa; Sulfamethoxazole; Suppression, Genetic; Trimethoprim

2009
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA.
    Bioorganic & medicinal chemistry letters, 2013, Apr-15, Volume: 23, Issue:8

    Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Molecular Chaperones; Periplasmic Binding Proteins; Structure-Activity Relationship; Thiourea

2013
The activity of rosoxacin, fosfomycin, cefotiam, and spectinomycin on beta-lactamase producing Neisseria gonorrhoeae.
    The British journal of venereal diseases, 1984, Volume: 60, Issue:3

    Topics: 4-Quinolones; Anti-Bacterial Agents; Cefotaxime; Cefotiam; Fosfomycin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillinase; Quinolines; Quinolones; Spectinomycin

1984
In vitro mutagenesis of Bacillus subtilis by using a modified Tn7 transposon with an outward-facing inducible promoter.
    Applied and environmental microbiology, 2008, Volume: 74, Issue:11

    Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacteriocins; DNA Transposable Elements; Drug Resistance, Bacterial; Fosfomycin; Gene Order; Mutagenesis, Insertional; Peptides; Plasmids; Promoter Regions, Genetic; Recombination, Genetic; Spectinomycin; Xylose

2008